Drug
Inhaled Human Insulin (Exubera®)
Inhaled Human Insulin (Exubera®) is a pharmaceutical drug with 5 clinical trials. Historical success rate of 60.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
60.0%
Based on 3 completed trials
Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
2(40%)
Phase Distribution
Ph phase_4
4
80%
Ph phase_3
1
20%
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
4(80.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
60.0%
3 of 5 finished
Non-Completion Rate
40.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(2)
Detailed Status
Completed3
Terminated2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
60.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (20.0%)
Phase 44 (80.0%)
Trials by Status
completed360%
terminated240%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_4
A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®
NCT00391027
terminatedphase_4
A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®
NCT00356421
terminatedphase_4
A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.
NCT00437489
completedphase_4
A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus
NCT00367445
completedphase_3
Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes
NCT00424411
Clinical Trials (5)
Showing 5 of 5 trials
NCT00391027Phase 4
A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®
NCT00356421Phase 4
A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®
NCT00437489Phase 4
A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.
NCT00367445Phase 4
A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus
NCT00424411Phase 3
Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5